Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pimecrolimus vs betamethasone for skin barrier restoration in atopic dermatitis (intra-patient right/left arm study)
2004-004824-11Phase 4Completed
- Sponsor
- Universitätsklinikum Schleswig-Holstein
- Start
- Oct 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of pimecrolimus and betamethasone in atopic dermatitis (AD) (2 arms), sponsored by Universitätsklinikum Schleswig-Holstein. Primary endpoint: Change in transepidermal water loss (TEWL). Started Oct 2005; status: completed.
02
Drugs
pimecrolimusbetamethasone
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2004-004824-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004824-11.